Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
2,765,928
-
Share change
-
+436,277
-
Total reported value
-
$5,781,309
-
Price per share
-
$2.09
-
Number of holders
-
31
-
Value change
-
+$912,474
-
Number of buys
-
18
-
Number of sells
-
8
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2025
As of 30 Sep 2025,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,765,928 shares.
The largest 10 holders included
Bleichroeder LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, UNITED CAPITAL FINANCIAL ADVISORS, LLC, and Imprint Wealth LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.